Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2007
11/22/2007WO2006080021A3 Multistep reaction lateral flow capillary device
11/22/2007WO2006065658A3 A physiogenomic method for predicting clinical outcomes of treatments in patients
11/22/2007WO2006064505A3 A single-step platform for on-chip integration of bio-molecules
11/22/2007WO2006044352A3 Canine cholecystokinin 1 receptor materials and their use
11/22/2007WO2006020470A3 Promotion of axonal regeneration
11/22/2007WO2006020126A3 Method for providing protein microarrays
11/22/2007WO2005099419A3 Manipulation and/or detection of biological samples or other objects
11/22/2007WO2005079279A3 High throughput screening methods for fuel compositions
11/22/2007WO2005067667A3 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
11/22/2007WO2005067478A3 Recombinant icosahedral virus like particle production in pseudomonads
11/22/2007WO2005044840A3 Modulation of anergy and methods for isolating anergy-modulating compounds
11/22/2007WO2003100377A3 Improved detection system and method of detection
11/22/2007WO2003100074A3 Animal genotyping method
11/22/2007WO2003064601A3 Adult human olfactory stem cell
11/22/2007WO2003041483A3 Method to study and mechanisms of biofilm-related antibiotic resistance
11/22/2007US20070271619 Diagnostic and Therapeutic Use of the Human Dax-1 Gene and Protein for Neurodegenerative Diseases
11/22/2007US20070270492 Nananoic acid derivatives as dipeptidyl peptidase inhibitors
11/22/2007US20070270488 Treatment and Assays
11/22/2007US20070270455 INHIBITION OF NF-kB
11/22/2007US20070270418 Inhibitors of P38 and Methods of Using the Same
11/22/2007US20070270388 Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid
11/22/2007US20070270351 Methods and Reagents for Regulation of Cellular Responses in Biological Systems
11/22/2007US20070270343 Insulin-like growth factor polypeptide; for treating solid tumors having cells expressing IGFBP-3 receptors
11/22/2007US20070270335 Methods for alleviating deleterious effects of 3-deoxyglucosone
11/22/2007US20070270330 Preventing airway mucus production by administration of egf-r antagonists
11/22/2007US20070269906 Interrupted, gravity-promoted, diffused flow chromatography strip testing device and method
11/22/2007US20070269905 Method for characterizing a local magnetic field, and device for carrying out the method
11/22/2007US20070269904 Colloidal nanoparticle, such as quantum dot bearing one or more of the ligand; and a bioconjugate characterized by a nanoparticle bearing one or more of the ligand conjugated to a biomolecule; thiol or other groups for attaching to an inorganic particle
11/22/2007US20070269903 Processes for receptor screening
11/22/2007US20070269902 Antibody complexes and methods for immunolabeling
11/22/2007US20070269900 Use of Conductive or Semiconductive Polymers in Chemical Sensors for the Detection of Nitro Compounds
11/22/2007US20070269898 Amino Acid Sequences Essential to Neuron Specific Gene Expression
11/22/2007US20070269897 Apparatus for analyzing particles in urine and method thereof
11/22/2007US20070269896 Reagent and method for classifying leucocytes
11/22/2007US20070269895 Methods for quantitative proteome analysis of glycoproteins
11/22/2007US20070269893 Device for Collecting Blood and Separating Blood Constituents, Method for Separating Blood Constituents and Use of Said Device
11/22/2007US20070269854 Method and Device for Measuring an Enzymatic Activity in a Body Fluid
11/22/2007US20070269847 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
11/22/2007US20070269846 drug screening a candidate substrates for mammalian cells or mammalian cell line which are leukemia cells or a leukemia cell line; drug targeted anticarcinogenic agents
11/22/2007US20070269845 Method of Generating and Isolating Tumour Cells
11/22/2007US20070269842 Assay for Acetyltransferases and Acetyltransferase Substrates
11/22/2007US20070269841 Determination of concentration of fk778 by competitive immunoassay
11/22/2007US20070269840 In-situ equilibrium dialysis
11/22/2007US20070269839 Preparation of spheres for diagnostic tests
11/22/2007US20070269837 Devices and methods for fluorescent inspection and/or removal of material in a sample
11/22/2007US20070269836 Methods and compositions for the diagnosis of venous thromboembolic disease
11/22/2007US20070269835 Reagent for determining laminin 5 antigen in biological sample and assay method
11/22/2007US20070269834 Methods and compositions for development of drug screening procedures and diagnostic tools
11/22/2007US20070269833 consisting of galectin-3 and chondroitin oligosaccharide and methods for seperating and detecting the chondroitin oligosaccharide in a sample using the immobilized complex
11/22/2007US20070269832 Novel affinity labels
11/22/2007US20070269831 Method for Early Detection of Ovarian Cancer
11/22/2007US20070269830 Process for the Identification of New Medical Targets
11/22/2007US20070269826 Angular-dependent metal-enhanced fluorescence
11/22/2007US20070269821 An analytical test for an analyte comprises a base with a reaction area and a visualization area, a capture species on the base in the visualization area comprising nucleic acid, and analysis chemistry reagents on the base in the reaction area
11/22/2007US20070269816 Mutational profiles in hiv-1 protease correlated with phenotypic drug resistance
11/22/2007US20070269814 Method of pathogen or chemical detection
11/22/2007US20070269812 System for detecting protease
11/22/2007US20070269808 Wnt receptor compositions and methods
11/22/2007US20070269802 Ranbp2 as Modifiers of the Pten/Igf Pathway and Methods of Use
11/22/2007US20070269800 Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases
11/22/2007US20070269799 Nucleic acid amplification methods
11/22/2007US20070269798 Epitope-captured antibody display
11/22/2007US20070269796 Microscope apparatus and cell observation method
11/22/2007US20070269795 by simulating in vitro a passage of the eggs through the gastrointestinal passage of a swine with regard to chronological sequence and medium; decreasing enzyme and salt concentrations and thereby inducing the larvae to shed from the eggs and the shading shows viability
11/22/2007US20070269502 Stable Liposome Compositions Comprising Lipophilic Amine Containing Pharmaceutical Agents
11/22/2007US20070269462 Novel exoenzyme toxin of Aeromonas salmonicida, and uses therefor
11/22/2007US20070269452 Methods and compositions for the diagnosis and treatment of cancer
11/22/2007US20070269445 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a PRRSV and a method of detecting a PRRSV
11/22/2007US20070269441 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
11/22/2007US20070269439 Use in diagnosis and treatment of cytokine disorders such as tumor metastasis, angiogenesis, cellular migration and ovulation, as well as neurogenesis
11/22/2007US20070269434 TAT-041 and methods of assessing and treating cancer
11/22/2007US20070269433 Cell cycle progressional proteins
11/22/2007US20070269432 Method of Diagnosing Breast Cancer
11/22/2007US20070269431 Protein Involved In Cancer
11/22/2007US20070269425 Anti-Idiotype Antibodies of the Human Monoclonal Antibody Sc-1, and Their Production and Use
11/22/2007US20070269423 kit comprises a nucleic acid, use for detection and treatment of human cancers by inhibiting the enzyme activities; biodrug as anticarcinogenic agents
11/22/2007US20070269421 Diagnostics and Therapeutics for Diseases Associated with Plasma Glutamate Carboxypeptidase (Pgcp)
11/22/2007US20070269420 Compounds, Compositions and Methods for Treatment and Prophylaxis of Hepatitis C Viral Infections and Associated Diseases
11/22/2007US20070269382 Nanoparticles and Their Use for Multifunctional Bioimaging
11/22/2007US20070269380 Methotrexate-modified nanoparticles and related methods
11/22/2007US20070269379 Penetration Enhancer Combinations for Transdermal Delivery
11/22/2007US20070269377 Method of Producing Partial Peptide of Enolase Protein from Plasmodium Falciparum
11/22/2007US20070269372 monoclonal antibodies or fragment thereof which binds a cell surface glycoprotein antigen located on the surface of human multiple myeloma tumor cells; for therapeutic, screening, diagnostic and cell purification purposes
11/22/2007US20070269346 System and method for limiting sensor exposure to ozone
11/22/2007US20070269345 Chip-Based Flow Cytometer Type Systems for Analyzing Fluorescently Tagged Particles
11/22/2007US20070269344 Method for Producing Bioassay Plate by Stacking Two Substrates Together and Bioassay Plate
11/22/2007US20070268734 Thermoplastic Plastic and Method for Producing the Same
11/22/2007US20070268489 Device and method for invetigating analytes in liquid suspension or solution
11/22/2007US20070266803 sample is transported in the analytical element in a capillary-active channel from a sample application opening to the determination site for the sample and in which the capillary-active channel is essentially formed by a carrier and a cover; device for withdrawing liquid samples for analysis
11/22/2007US20070266778 Method and Apparatus for Ultrasonic Determination of Hematocrit and Hemoglobin Concentrations
11/22/2007US20070266777 Apparatus which utilizes capillary flow to separate unwanted components from blood sample prior to preferential analyte detection
11/22/2007US20070266775 Method for producing a biosensor
11/22/2007US20070266774 Method for evaluating asthma control
11/22/2007US20070266772 Internal combustion engine control device
11/22/2007US20070266771 Method of an Apparatus for Detecting the Presence of Signature Volatile Compounds From Materials in a Confined Environment
11/22/2007US20070266769 Device and method for the selective determination of the quantity of oil mist
11/22/2007US20070266766 Breath alcohol-measuring device, process and system
11/22/2007US20070266765 Oxygen depletion sensor
11/22/2007DE202007013040U1 Laborgerät Laboratory equipment
11/22/2007DE19815273B4 Verfahren und Vorrichtung zum Untersuchen von Kraftfahrzeug-Abgasen Method and device for inspecting motor vehicle exhaust gases
1 ... 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 ... 3937